OverviewSuggest Edit

Hancock Jaffes is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). The Company develops bioprosthetic implantable devices for cardiovascular disease. Its Bioprosthetic Heart Valve (BHV), is a bioprosthetic, pig heart valve designed to function like a native heart valve, and designed to provide a patient greater functional performance than available devices.
TypePublic
Founded1987
HQIrvine, US
Websitehancockjaffe.com

Latest Updates

Employees (est.) (Mar 2020)12(+34%)
Revenue (FY, 2019)$31.2 K(-83%)
Share Price (Nov 2020)$0.3 (+3%)
Cybersecurity ratingCMore

Key People/Management at Hancock Jaffe

Robert Berman

Robert Berman

Chief Executive Officer, Director
Hamed Alavi

Hamed Alavi

Director of Research and Development and Quality
Francis Duhay

Francis Duhay

Director
Robert Gray

Robert Gray

Director
Matthew Jenusaitis

Matthew Jenusaitis

Director
Sanjay Shrivastava

Sanjay Shrivastava

Director
Show more

Hancock Jaffe Office Locations

Hancock Jaffe has an office in Irvine
Irvine, US (HQ)
70 Doppler
Show all (1)

Hancock Jaffe Financials and Metrics

Hancock Jaffe Revenue

Hancock Jaffe's revenue was reported to be $31.24 k in FY, 2019
USD

Net income (Q2, 2020)

(1.6m)

EBIT (Q2, 2020)

(1.5m)

Market capitalization (17-Nov-2020)

16.7m

Closing stock price (17-Nov-2020)

0.3

Cash (30-Jun-2020)

1.6m

EV

15.9m
Hancock Jaffe's current market capitalization is $16.7 m.
Annual
USDFY, 2018FY, 2019

Revenue

186.6k31.2k

General and administrative expense

6.5m4.9m

R&D expense

1.2m2.2m

Operating expense total

8.0m7.1m
Quarterly
USDQ2, 2018Q3, 2018Q1, 2019Q2, 2019Q1, 2020Q2, 2020

Revenue

83.4k41.7k31.2k

General and administrative expense

2.9m1.1m1.3m1.5m997.9k839.7k

R&D expense

280.4k424.6k313.0k428.3k510.6k706.2k

Operating expense total

3.2m1.5m1.6m2.0m1.5m1.5m
Annual
USDFY, 2018FY, 2019

Cash

2.7m1.3m

Accounts Receivable

32.0k

Prepaid Expenses

64.3k116.6k

Current Assets

2.8m1.4m
Quarterly
USDQ2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

5.9m4.2m2.8m4.5m2.9m720.1k1.6m

Accounts Receivable

29.0k28.1k26.5k

Prepaid Expenses

137.6k146.7k166.6k164.6k116.9k120.0k220.8k

Current Assets

6.1m4.4m2.9m4.6m3.1m840.1k1.8m
Annual
USDFY, 2018FY, 2019

Net Income

(13.0m)(7.6m)

Depreciation and Amortization

133.4k123.7k

Accounts Payable

(294.1k)144.1k

Cash From Operating Activities

(6.4m)(5.9m)
Quarterly
USDQ2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(9.8m)(11.3m)(1.6m)(3.5m)(5.3m)(1.2m)(2.8m)

Depreciation and Amortization

66.4k99.8k22.5k50.0k85.1k19.7k45.0k

Accounts Payable

(10.0k)(148.6k)18.7k119.8k134.2k176.6k346.2k

Cash From Operating Activities

(3.2m)(4.9m)(1.5m)(2.9m)(4.3m)(1.2m)(2.5m)
USDQ2, 2018

Financial Leverage

1.6 x
Show all financial metrics

Hancock Jaffe Cybersecurity Score

Cybersecurity ratingPremium dataset

C

71/100

SecurityScorecard logo

Hancock Jaffe Online and Social Media Presence

Embed Graph

Hancock Jaffe News and Updates

Hancock Jaffe Successfully Starts First-in-Human VenoValve Study

First VenoValve Successfully Implanted, No Early Signs of Adverse Events First VenoValve Successfully Implanted, No Early Signs of Adverse Events

Hancock Jaffe Appoints Chris Sarner as Vice President of Regulatory Affairs and Quality Assurance

IRVINE, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health, today announced that Chris Sarner will be joining the company as its Vice President of Regulatory Affairs an…

Hancock Jaffe Enters into Sponsored Research Agreement for CoreoGraft with World-Renowned Texas Heart Institute

IRVINE, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health, announced today that it has entered into a Sponsored Research Agreement with Texas Heart Institute for the d…

Hancock Jaffe Submits Application to INVIMA for First-In-Human VenoValve Trial in Colombia

IRVINE, Calif., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health, announced today that it has completed and submitted its application to INVIMA (the Colombian equivalent of …

Diamond Equity Research Initiates Coverage on Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI) with a Valuation of $6.60 Per Share

NEW YORK, Sept. 20, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – Diamond Equity Research, a leading equity research and corporate access firm with a focus on small capitalization public companies, has initiated coverage of Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI). The in-depth 21-page initiat…

Hancock Jaffe to Present at Fourth Annual Robins Equity Research Roundup Conference

IRVINE, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health, announced today that it will present at the Fourth Annual Robins Equity Research Roundup, September 24, 25,…
Show more

Hancock Jaffe Frequently Asked Questions

  • When was Hancock Jaffe founded?

    Hancock Jaffe was founded in 1987.

  • Who are Hancock Jaffe key executives?

    Hancock Jaffe's key executives are Robert Berman, Hamed Alavi and Francis Duhay.

  • How many employees does Hancock Jaffe have?

    Hancock Jaffe has 12 employees.

  • What is Hancock Jaffe revenue?

    Latest Hancock Jaffe annual revenue is $31.2 k.

  • What is Hancock Jaffe revenue per employee?

    Latest Hancock Jaffe revenue per employee is $2.6 k.

  • Who are Hancock Jaffe competitors?

    Competitors of Hancock Jaffe include Histocell, Hera Health Solutions and Anchiano Therapeutics.

  • Where is Hancock Jaffe headquarters?

    Hancock Jaffe headquarters is located at 70 Doppler, Irvine.

  • Where are Hancock Jaffe offices?

    Hancock Jaffe has an office in Irvine.

  • How many offices does Hancock Jaffe have?

    Hancock Jaffe has 1 office.